Their results indicated that the positive rate of AABs including p53 and GAGE7 in lung cancer patients was not significantly different from that of healthy control, whereas we found no difference between GBU4-5 in lung cancers from controls (healthy control and benign lung disease control). This evidence concerns the gene TP53 and lung cancer.